Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1139 in Plaque Psoriasis
NCT07758075Phase 2Not yet recruiting
- Sponsor
- Hengrui Therapeutics
- Start
- Aug 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-1139 in plaque psoriasis, sponsored by Hengrui Therapeutics. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
SHR-1139
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07758075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07758075.